Posted by Stacy Sanders on Jan 30th, 2025
Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 108,500 shares, a decline of 18.5% from...
More of this article »